Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer
A phase 3 trial demonstrates multiple benefits of adding the androgen-receptor inhibitor darolutamide to standard therapy.
Massachusetts General Hospital's Pain Management Center offers advanced pain management therapies for patients experiencing moderate to severe levels of cancer-related pain.
PET-CT services are available in Boston, Chelsea and Danvers.
Los expertos de nuestro programa ofrecen atención tanto para las formas de crecimiento lento como las más agresivas de cáncer de próstata.
Los expertos de nuestro programa ofrecen atención tanto para las formas de crecimiento lento como las más agresivas de cáncer de próstata.
يُقدِّم خبراء برنامجنا الرعاية لأشكال سرطان البروستاتا البطيئة النمو والعدوانية.
麻省总医院前列腺癌治疗项目的专家致力为患有生长缓慢和侵袭性前列腺癌的患者提供治疗。
Read the latest news from Massachusetts General Hospital.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.